SEC Form 4 research
| Issuer | BlossomHill Therapeutics, Inc. |
|---|---|
| Tickers | BLSM |
| Reporting owners | 17 |
| Officers and directors | 5 |
| Last public filing | 2026-08-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-12 | 2026-08-10 | GORDON CARL L | P | 625,000 | $16 | Not reported |
| 2026-08-12 | 2026-08-10 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC | P | 625,000 | $16 | Not reported |
| 2026-08-10 | 2026-08-06 | Oxnard Geoffrey Raymond | A | 61,783 | $0 | Not reported |
| 2026-08-10 | 2026-08-10 | Liptak Vincent Paul | P | 2,200 | $16 | Not reported |
| 2026-08-10 | 2026-08-07 | Liptak Vincent Paul | P | 2,500 | $15.8 | Not reported |
| 2026-08-10 | 2026-08-06 | Liptak Vincent Paul | A | 46,561 | $0 | Not reported |
| 2026-08-10 | 2026-08-06 | Agrawal Sundeep | A | 23,904 | $0 | Not reported |
| 2026-08-10 | 2026-08-06 | Cui Jingrong Jean | A | 676,205 | $0 | Not reported |
| 2026-08-10 | 2026-08-06 | Li Yishan | A | 112,701 | $0 | Not reported |
| 2026-08-10 | 2026-08-10 | Keyes Jason A | P | 700 | $16 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.